Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy symbols : Ortx save search
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
children approved therapeutics therapy
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
fda children approval therapeutics therapy
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Published: 2024-01-24 (Crawled : 10:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
rare acquisition global therapy
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: -5.13%
H: 5.41%
C: 3.46%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.18%
H: 0.43%
C: 0.25%
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
|
| O: 5.62%
H: 3.72%
C: -4.26%
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
|
| O: 0.59%
H: 1.35%
C: 0.6%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: -0.46%
H: 5.56%
C: -1.12%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: 0.65%
H: 2.59%
C: 0.86%
america therapy growth market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: 3.87%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: -3.37%
H: 4.51%
C: 4.51%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -0.25%
H: 0.68%
C: 0.48%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
|
| O: 0.0%
H: 38.05%
C: 23.01%
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.29%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: 0.92%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: -5.76%
H: 16.36%
C: 15.07%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: -2.43%
H: 0.0%
C: 0.0%
research growing therapy market
Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published: 2023-11-03 (Crawled : 23:00) - prnewswire.com
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
| Email alert
Add to watchlist
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
| Email alert
Add to watchlist
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
| Email alert
Add to watchlist
AAPL | $165.91 0.55% 0.55% 48M
|
Electronic Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
| Email alert
Add to watchlist
america therapy market
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: -0.68%
H: 3.23%
C: 1.55%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.62%
H: 4.57%
C: 2.04%
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
|
| O: 0.0%
H: 11.57%
C: 6.4%
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.99%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -0.86%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: -0.75%
H: 7.14%
C: 6.12%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: 0.0%
H: 4.4%
C: 3.29%
drug set therapy growth market
Orchard Therapeutics Presents Data from Research Programs at ASGCT Demonstrating the Ability of HSC Gene Therapy to Address Larger Indications
Published: 2023-05-18 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.12%
H: 1.85%
C: -5.91%
research therapeutics therapy
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published: 2023-03-16 (Crawled : 02:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: 0.44%
H: 0.29%
C: 0.29%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: -6.05%
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
|
| O: -0.55%
H: 6.69%
C: 1.95%
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
|
| O: -1.11%
H: 2.97%
C: 2.23%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: -0.49%
H: 0.39%
C: 0.36%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: -2.65%
H: 14.55%
C: 9.09%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: -2.29%
H: 3.52%
C: -0.78%
drug therapy market
Global Gene Therapy Market to Grow by $4.61 Billion During 2023-2027
Published: 2023-03-14 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
|
| O: 1.01%
H: 0.43%
C: 0.29%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.01%
H: 7.6%
C: 7.6%
GBIO | News | $2.805 0.18% 0.18% 150K
|
Health Technology
|
| O: 3.79%
H: 2.61%
C: -1.57%
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
|
| O: 1.4%
H: 1.39%
C: 0.07%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -1.23%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: 0.9%
H: 4.46%
C: 2.68%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: 2.79%
H: 8.53%
C: 0.78%
global therapy market
Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas
Published: 2022-10-10 (Crawled : 12:00) - biospace.com/
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.23%
H: 4.6%
C: 0.13%
potential therapy
Orchard Therapeutics Extends Runway into 2024, Focusing HSC Gene Therapy Platform Exclusively on Severe Neurometabolic Diseases and Research Platform
Published: 2022-03-30 (Crawled : 12:00) - biospace.com/
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.0%
H: 2.44%
C: -5.13%
research therapeutics therapy platform disease
Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.83 3.43% 3.31% 380K
|
Health Technology
| Email alert
Add to watchlist
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
| Email alert
Add to watchlist
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
| Email alert
Add to watchlist
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
novartis gene therapy therapy
Orchard Therapeutics Outlines Comprehensive Presence at the European Society of Gene & Cell Therapy Congress
Published: 2021-10-13 (Crawled : 12:00) - biospace.com/
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 3.43%
H: 3.79%
C: 1.9%
europe therapy
Global Gene and Cell Therapy (GCT) Market Report 2021-2026: Competitive Developments, Strategies, Mergers and Acquisitions and New Product Developments
Published: 2021-10-05 (Crawled : 17:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.1%
H: 0.62%
C: 0.0%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.43%
H: 1.41%
C: -3.29%
acquisition therapy acquisitions new product merge
Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and Discusses Potential Future Applications at Virtual R&D Investor Event
Published: 2021-09-14 (Crawled : 10:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.73%
H: 1.02%
C: -1.36%
potential gene therapy therapy gene therapies
Global Gene Therapy Market Report 2021: Adeno-associated Virus Vectors - A Leading Platform for Gene Therapy
Published: 2021-07-13 (Crawled : 11:00) - prnewswire.com
QURE | $4.83 3.43% 3.31% 380K
|
Health Technology
|
| O: -0.64%
H: 1.28%
C: -1.0%
SRPT | $117.15 1.32% 1.31% 890K
|
Health Technology
|
| O: -0.88%
H: 1.98%
C: -1.13%
SGMO | News | $0.5151 0.7% 0.7% 1.3M
|
Health Technology
|
| O: -0.49%
H: 1.63%
C: 0.0%
RGNX | $15.68 -0.06% -0.06% 440K
|
Health Technology
|
| O: -0.51%
H: 0.95%
C: -1.06%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -4.26%
NTLA | $21.85 1.3% 1.28% 1M
|
Health Technology
|
| O: -0.48%
H: 1.36%
C: -2.65%
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.35%
H: 1.01%
C: 0.27%
EDIT | News | $5.62 2.37% 2.31% 1.7M
|
Health Technology
|
| O: -0.15%
H: 1.2%
C: -4.78%
CRSP | News M | $55.7 1.18% 1.17% 1M
|
Health Technology
|
| O: -0.47%
H: 0.76%
C: -3.24%
BLUE | $0.9568 -6.2% -6.61% 4.4M
|
Health Technology
|
| O: -0.7%
H: 0.95%
C: -2.43%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: -2.09%
ALNY | $145.78 0.95% 0.94% 390K
|
Health Technology
|
| O: -0.56%
H: 1.51%
C: -0.23%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: -0.25%
H: 0.25%
C: -1.78%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: -4.83%
gene therapy therapy gene therapies
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
Published: 2021-07-01 (Crawled : 06:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 5.01%
H: 0.43%
C: -6.94%
gene therapy therapy collaboration announces collaboration gene therapies commercialization hereditary angioedema
Global Gene Therapy Market to Reach $2.7 Billion by 2026
Published: 2021-06-29 (Crawled : 14:15) - prnewswire.com
QURE | $4.83 3.43% 3.31% 380K
|
Health Technology
|
| O: 0.1%
H: 1.22%
C: -0.26%
SRPT | $117.15 1.32% 1.31% 890K
|
Health Technology
|
| O: 0.0%
H: 0.25%
C: -2.43%
SGMO | News | $0.5151 0.7% 0.7% 1.3M
|
Health Technology
|
| O: -0.91%
H: 1.08%
C: -2.66%
RGNX | $15.68 -0.06% -0.06% 440K
|
Health Technology
|
| O: -0.26%
H: 1.59%
C: -1.13%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.13%
H: 0.1%
C: -8.26%
NTLA | $21.85 1.3% 1.28% 1M
|
Health Technology
|
| O: -2.19%
H: 17.95%
C: 16.17%
GILD | $66.95 0.29% 0.28% 5.6M
|
Health Technology
|
| O: -0.04%
H: 0.53%
C: 0.38%
EDIT | News | $5.62 2.37% 2.31% 1.7M
|
Health Technology
|
| O: 2.07%
H: 3.99%
C: 2.67%
CRSP | News M | $55.7 1.18% 1.17% 1M
|
Health Technology
|
| O: -0.41%
H: 1.48%
C: -0.34%
BLUE | $0.9568 -6.2% -6.61% 4.4M
|
Health Technology
|
| O: -0.26%
H: 0.64%
C: -3.25%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -2.44%
ALNY | $145.78 0.95% 0.94% 390K
|
Health Technology
|
| O: 0.42%
H: 0.15%
C: -0.62%
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
|
| O: -0.68%
H: 1.6%
C: 0.23%
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
|
| O: 0.0%
H: 0.59%
C: -2.96%
gene therapy therapy gene therapies market
Orchard Therapeutics Announces Regulatory and Clinical Updates for Lead Gene Therapy Programs
Published: 2021-06-29 (Crawled : 12:00) - biospace.com/
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.13%
H: 0.1%
C: -8.26%
gene therapy therapy gene therapies
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.